Lara is a Vice President at Lightstone Ventures (LSV). She focuses on investments in the medical device and biopharmaceutical sectors and is based out of the firm’s Menlo Park, CA office.
Lara brings over ten years of relevant, multidisciplinary healthcare experience across a range of therapeutic areas and technologies to the Lightstone team. Prior to joining Lightstone, Lara was a Senior Manager at Thoratec and was responsible for North America commercial product marketing for the HeartMate LVAD franchise. Upon first joining Thoratec, Lara led the company’s market and center development initiatives to drive HeartMate II® growth in existing and new large cardiac, non-transplant hospitals.
Lara’s earlier career experience includes strategy consulting with the Boston Consulting Group (BCG), where notable projects included refocusing the R&D strategy of a major pharmaceutical company and assessing the Affordable Care Act’s long-term impact on each of the involved industries: payers, providers, hospitals, biotech/pharma, and medical devices. Before BCG, Lara spent three years in the medical device group of Global Prior Art, a boutique firm specializing in intellectual property management.
Lara holds master and bachelor degrees from the Massachusetts Institute of Technology. While a graduate student at MIT, Lara was a member of the Langer Lab, a Whitaker Fellow, and a recipient of the John Wulff Award for Excellence in Teaching. Her research focused on scaffolds for tissue engineering, specifically for nerve regeneration in the spine. Lara also holds an MBA from Tuck (Dartmouth) where she was a Forté Fellow. She is co-editor of the graduate text Physical Metallurgy Principles, 4th ed.
M.B.A from the Amos Tuck School of Business Administration at Dartmouth College
M.Eng. in Materials Science and Engineering from the Massachusetts Institute of Technology (MIT)
S.B. in Materials Science and Engineering from the Massachusetts Institute of Technology (MIT)